Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Item

http://www.wikidata.org/entity/Q33989952

Q33989952

about

Beta-blockers for preventing stroke recurrence Beta-blockers for hypertension Treatment of hypertension in peripheral arterial disease Beta-blockers for hypertension Beta-blockers for preventing stroke recurrence Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease Calcium channel blockers versus other classes of drugs for hypertension Walking for hypertension Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia Beta blockers for preventing stroke recurrence Treatment of hypertension in peripheral arterial disease Angiotensin converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1-3) non-diabetic chronic kidney disease Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis Carvedilol in hypertension treatment Manidipine-delapril combination in the management of hypertension Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke: Traditional and Bayesian Network Meta-analysis of Randomized Trials Timeline of History of Hypertension Treatment Understanding and treating hypertension in diabetic populations A Review of Nebivolol Pharmacology and Clinical Evidence Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses Does it matter where we measure blood pressure?Calcium channel blockers Pre-hypertension: how low to go and do drugs have a role?Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients The perils of surrogate endpoints Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and Novel Uses of Office-Based Measures of Arterial Compliance Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence Evaluating and treating cardiometabolic risk factors: a case discussion Stroke prevention in diabetes and obesity Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy Multivariate risk assessment and risk score cards in hypertension Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases Secular Trends in Prescription Patterns of Single-Pill Combinations of an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Plus a Thiazide Diuretic for Hypertensive Patients in Taiwan The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials

P2860

Q24193102-010FA4B9-923B-4259-9A11-347E422D65F6 Q24201511-84E3007F-9628-4E17-923B-FCAFA0114226 Q24201969-D605EA93-CA44-4B2F-8C15-37899194A665 Q24202812-E98A9512-AF74-46EC-BF61-8CE238BD47A4 Q24202904-2EE943EE-26B0-4F05-A691-41D3A7801029 Q24235834-0483D401-6C7A-4FC4-A447-1B4B6C5ACBD7 Q24236584-4E8B1B7F-100F-468D-9BFE-BAB516791855 Q24236765-2AE6C4D5-EBB9-43EC-930B-23FAE755DDFF Q24240206-A75DF150-E53D-4AE2-BBD2-92ECEE90B509 Q24240367-7B2B82D6-B749-4E10-BF09-23F455B1FF81 Q24240538-EADC987F-FED9-470E-87F3-133164A2DB61 Q24241947-7918A6E5-ACDA-441C-AE35-B6F048A4B6FB Q24545775-A383102F-D700-4172-91C3-611BD8A7E7C6 Q24642654-F94FAC26-A83F-427A-B8A6-F90684EB5749 Q24654799-5F69E3E4-5D9B-4824-9BF3-EF083DC68991 Q26747669-54363DF7-9A64-425D-9932-E1F8B3DE406B Q26768219-6587E93C-AC02-4996-8E1A-D41AAE03513E Q26778662-AD0796BA-306E-44C4-9580-79BF74F85CFC Q26801287-FB95AD79-A367-440C-9351-130A0836D02C Q26824261-0470A1CC-F5A5-4558-A3DB-F7967582BE91 Q26825409-AEBA257E-0CFA-4C78-BD42-600603DA5140 Q26861630-053EAC3B-C20E-437E-92D3-888FC9785959 Q26996563-7DAEB144-6A30-4E6D-9C39-85415EA7DF72 Q26999237-A6AF6D9A-7270-459F-B204-6C983EB468C2 Q27003120-0F1E4E39-59AB-4667-922C-5D14B2FD1CBF Q27007552-D96429B4-22D2-4C0A-9415-D2116CE99D4D Q27023161-BC0B544E-6529-455C-8172-7AAADD7588D9 Q27025740-FA3BE64E-8C9C-4883-8BD9-EFCD57B3BA0B Q27025943-144276C1-9872-49DB-8E63-2A880605C64B Q28073696-453D70DE-073E-4CE7-B186-04072C1138E5 Q28074644-80C392A6-13D3-485C-B554-5E23936A971E Q28196750-FFDDB070-F8E7-4CD0-93E9-E225DACBD29B Q28200179-A530E22F-99E1-440F-8F3B-602066C7DFAD Q28200196-E77D7F51-940B-47A9-B89A-76E9425EED2A Q28218811-9DA775A8-3CC6-4184-8A14-C8870E28FE05 Q28219606-12B46D10-D195-41BD-9731-04C7F21BA7CE Q28220999-A98718A6-2DC3-4523-A4B3-21A7A95B115F Q28270431-DD86EC31-DA8B-4933-8529-9967D781C7BD Q28468718-1B50B7E8-B6B7-4DE4-ABD6-B5D69E21EA51 Q28487721-51026AE0-5DFD-4AC1-BC9A-9130C0A89E4B

P2860

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Item

http://www.wikidata.org/entity/Q33989952

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue